tradingkey.logo
tradingkey.logo
Buscar

Senestech Inc

SNES
Añadir a la lista de seguimiento
1.480USD
+0.010+0.68%
Cierre 07/02, 13:00ETCotizaciones retrasadas 15 min
7.90MCap. mercado
PérdidaP/E TTM

Más Datos de Senestech Inc Compañía

SenesTech, Inc. develops and commercializes products for managing animal pest populations, initially rat populations, through fertility control. The Company’s product lines of fertility control products are: ContraPest, Evolve Rat, and Evolve Mouse. Its product, ContraPest, is a liquid bait containing the active ingredients 4-vinylcyclohexene diepoxide (VCD) and triptolide. ContraPest targets the reproductive systems of both male and female Norway and roof rats beginning with the first breeding cycle following consumption, which can lead to sustained reductions in the rat population. The Evolve Rat is a soft bait product that contains the active ingredient, cottonseed oil, which reduces fertility in both male and female rats. The Evolve Mouse, a modified version of soft bait technology containing the active ingredient cottonseed oil, which limits reproduction of male and female mice after one to two breeding cycles following consumption.

Información de Senestech Inc

Símbolo de cotizaciónSNES
Nombre de la empresaSenestech Inc
Fecha de salida a bolsaDec 08, 2016
Director ejecutivoFruendt (Joel L)
Número de empleados23
Tipo de seguridadOrdinary Share
Fin del año fiscalDec 08
Dirección777 W. Pinnacle Peak Road
CiudadPHOENIX
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal85027
Teléfono19287794143
Sitio Webhttps://senestech.com/
Símbolo de cotizaciónSNES
Fecha de salida a bolsaDec 08, 2016
Director ejecutivoFruendt (Joel L)

Ejecutivos de Senestech Inc

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Michael Edell
Mr. Michael Edell
Chief Operating Officer
Chief Operating Officer
4.00K
+25.00%
Mr. Matthew K. (Matt) Szot, CPA
Mr. Matthew K. (Matt) Szot, CPA
Independent Director
Independent Director
2.00
+50.00%
Mr. Thomas C. (Tom) Chesterman
Mr. Thomas C. (Tom) Chesterman
Chief Financial Officer, Executive Vice President, Treasurer, Secretary
Chief Financial Officer, Executive Vice President, Treasurer, Secretary
--
--
Dr. Jamie Bechtel, J.D., Ph.D.
Dr. Jamie Bechtel, J.D., Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Phil N. Grandinetti, III
Mr. Phil N. Grandinetti, III
Independent Director
Independent Director
--
--
Mr. Jake S. Leach
Mr. Jake S. Leach
Independent Director
Independent Director
--
--
Mr. Joel L. Fruendt
Mr. Joel L. Fruendt
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Joshua M. Moss
Mr. Joshua M. Moss
Independent Director
Independent Director
--
--
Ms. Lynn Y. Graham
Ms. Lynn Y. Graham
Independent Director
Independent Director
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Michael Edell
Mr. Michael Edell
Chief Operating Officer
Chief Operating Officer
4.00K
+25.00%
Mr. Matthew K. (Matt) Szot, CPA
Mr. Matthew K. (Matt) Szot, CPA
Independent Director
Independent Director
2.00
+50.00%
Mr. Thomas C. (Tom) Chesterman
Mr. Thomas C. (Tom) Chesterman
Chief Financial Officer, Executive Vice President, Treasurer, Secretary
Chief Financial Officer, Executive Vice President, Treasurer, Secretary
--
--
Dr. Jamie Bechtel, J.D., Ph.D.
Dr. Jamie Bechtel, J.D., Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Phil N. Grandinetti, III
Mr. Phil N. Grandinetti, III
Independent Director
Independent Director
--
--
Mr. Jake S. Leach
Mr. Jake S. Leach
Independent Director
Independent Director
--
--

Preguntas frecuentes

¿Quiénes son los cinco principales accionistas de Senestech Inc?

Los cinco principales accionistas de Senestech Inc son: Mr. Michael Edell

¿Cuántas instituciones poseen acciones de Senestech Inc (SNES)?

A fecha de 2026Q1, 36 instituciones poseen acciones de Senestech Inc, con un valor de mercado combinado de aproximadamente 1.80M, lo que representa el 34.07% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en 690081.00.